Clinical Trial: Efficacy and Safety of Neoadjuvant Node-Sparing Short-Course Radiotherapy Followed by CAPOX plus Retlirafusp Alfa (SHR-1701) in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Single-Arm, Multicenter Phase II Trial (China)

Posted On: 2026-11-10

China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Neoadjuvant Node-Sparing Short-Course Radiotherapy Followed by CAPOX plus Retlirafusp Alfa (SHR-1701) in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Single-Arm, Multicenter Phase II Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136157

Registration Time: 2026/11/06

Type: Interventional study

Primary Sponsor: Jiangsu Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341345

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy and Safety of Neoadjuvant Node-Sparing Short-Course Radiotherapy Followed by CAPOX plus Retlirafusp Alfa (SHR-1701) in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Single-Arm, Multicenter Phase II Trial (China)